Literature DB >> 9607895

Urinary cAMP activity in chronic renal failure.

M Z Mocan1, C Erem, S Ulusoy.   

Abstract

Forty-six patients with chronic renal failure and 17 healthy controls were examined to determine their urinary cyclic adenosine monophosphate (UcAMP) levels. In the study group, UcAMP levels were found to average 1542 picomoles; in the controls, 4612 pmoles (P<0.001). UcAMP activity decreased in tandem with the decline of the glomerular filtration rate. Hypertension was not found to have an additional effect on UcAMP levels, and there was no statistical difference in UcAMP levels between the normotensive and hypertensive patients (P>0.05).

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9607895     DOI： 10.1007/bf02550580

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  11 in total

1.  Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate.

Authors:  F Murad; C Y Pak
Journal:  N Engl J Med       Date:  1972-06-29       Impact factor: 91.245

2.  Excretion of cyclic 3',5'-adenosine monophosphate in renal insufficiency and primary hyperparathyroidism after stimulation with parathyroid hormone.

Authors:  H von Lilienfeld-Toal; R D Hesch; M Hüfner; C McIntosh
Journal:  Horm Metab Res       Date:  1974-07       Impact factor: 2.936

3.  Cell communication, calcium ion, and cyclic adenosine monophosphate.

Authors:  H Rasmussen
Journal:  Science       Date:  1970-10-23       Impact factor: 47.728

4.  Renal excretion of prostanoids and cyclic AMP in chronic partial ureteral obstruction of the rabbit.

Authors:  M Kekomäki; H Vapaatalo
Journal:  J Urol       Date:  1989-02       Impact factor: 7.450

5.  Prospective analysis of intraoperative and postoperative urinary cyclic adenosine 3',5'-monophosphate levels to predict outcome of patients undergoing reoperations for primary hyperparathyroidism.

Authors:  G E Darling; S J Marx; A M Spiegel; G D Aurbach; J A Norton
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

6.  Parameters of evaluation and correlation of renal phosphate handling and of parathyroid function in children.

Authors:  H Stark; B Eisenstein; M Davidovits
Journal:  Nephron       Date:  1989       Impact factor: 2.847

7.  Hyperparathyoidism: influence of glomerular filtration rate on urinary excretion of cyclic AMP.

Authors:  H Schmidt-Gayk; R Stengel; H Haueisen; M Hüfner; E Ritz; K H Jakobs
Journal:  Klin Wochenschr       Date:  1977-03-15

8.  Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.

Authors:  A E Broadus; J E Mahaffey; F C Bartter; R M Neer
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

9.  Transport and metabolism of adenosine 3':5'-monophosphate and N6, O2'-dibutyryl adenosine 3':5'-monophosphate by isolated renal tubules.

Authors:  E F Boumendil-Podevin; R A Podevin
Journal:  J Biol Chem       Date:  1977-10-10       Impact factor: 5.157

10.  Metabolism and excretion of exogenous adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate. Studies in the isolated perfused rat kidney and in the intact rat.

Authors:  R Coulson
Journal:  J Biol Chem       Date:  1976-08-25       Impact factor: 5.157
View more
  1 in total

1.  Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19.

Authors:  Xiaojie Bi; Wei Liu; Xuan Ding; Shuang Liang; Yufen Zheng; Xiaoli Zhu; Sheng Quan; Xiao Yi; Nan Xiang; Juping Du; Haiyan Lyu; Die Yu; Chao Zhang; Luang Xu; Weigang Ge; Xinke Zhan; Jiale He; Zi Xiong; Shun Zhang; Yanchang Li; Ping Xu; Guangjun Zhu; Donglian Wang; Hongguo Zhu; Shiyong Chen; Jun Li; Haihong Zhao; Yi Zhu; Huafen Liu; Jiaqin Xu; Bo Shen; Tiannan Guo
Journal:  Cell Rep       Date:  2021-12-28       Impact factor: 9.423
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.